Scottish textile technology helps cancer patients

October 15, 2012

Micro-encapsulated textiles, which offer added comfort as well as aroma-therapeutic benefits to cancer patients, are now being used in a luxury handmade headwear range, Asha.

The range is launched this week by Borders-based textile company, Murray Hogarth, who worked closely on the final product with Heriot-Watt University's School of and Design and South of Scotland Business Solutions (SoSBS).

The turbans, headscarves and accessories in the Asha range, offer a range of finishes such as lavender and other aromatherapy oils and thermo-regulated textiles, aimed at helping cancer patients.

One of the finishes incorporates minute, airtight, hard shell capsules containing a chosen scent being welded to the textile fibre. When the garment is worn, friction causes the capsules to burst, releasing a subtle fragrance, such as aloe vera or lavender.

There are many different types of micro-encapsulated textile finishes, everything from UV ray management and temperature regulation to vitamins and moisturisers, any of which could be incorporated to suit specific needs.

Professor Alison Harley, Head of Heriot-Watt University's School of Textiles and Design, said, "Smart textiles are a fast-developing sector that offers enormous potential within the healthcare industry.

"This collaboration showcases our close work with industry, including many small and medium size textile businesses in Scotland, to help them find ways to add value and grow their business.

"Murray Hogarth is a great example of the ways in which we can help Scottish textile businesses to develop and bring exciting new products to market."

Jim McVee, Business Development Manager at the School of Textiles an Design said, "My brief was to assist Murray Hogarth with the development of a well being garment for women who are having chemo or radiotherapy and which could help with some of the side effects associated with the treatment.

"Fashion Technology at the School developed prototypes and we also recommended that an enhanced finish be added to the fabrics to add further value to the product. This would turn an ordinary garment in to one which would offer the customer different solutions to potential side effects of their treatment. We also helped Murray Hogarth to find a manufacturer who could produce the quantities they needed."

Asha will be supporting Maggie's Cancer Charity by donating 10 per cent of all sales to the charity.

Maggie's Senior Corporate Fundraising Manager, Gemma Branney, said, "Any kind of work or research, such as that carried out by Heriot-Watt University's School of Textiles and Design, to develop to help women with cancer-related hair loss is hugely welcome.

"We are also delighted that Asha are choosing to donate 10% of their sales to Maggie's.

"At Maggie's we rely on the generosity of the communities surrounding our centres to ensure that we can open our doors to support local people affected by cancer. We would like to thank Asha for raising funds to help us keep our doors open."

Related Stories

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.